Cadila Healthcare Working on Needle-free, 2-Dose Vaccine

The drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virologically confirmed symptomatic Covid-19 cases compared to the placebo. The vaccine candidate is administered on day 1, day 28 and day 54.

Source: The Economic Times - April 2, 2021 Category: Consumer Health News Source Type: news